Dermatology Drug Market - Global Outlook and Forecast 2021-2027

March 2021 | 103 pages | ID: D181C7A110A0EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Dermatology Drug in global, including the following market information:

Global Dermatology Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Dermatology Drug Market Sales, 2016-2021, 2022-2027, (K Units)

Global top five Dermatology Drug companies in 2020 (%)

The global Dermatology Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dermatology Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dermatology Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Dermatology Drug Market Segment Percentages, By Type, 2020 (%)

• External Use
• Oral
• Injection

Global Dermatology Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Dermatology Drug Market Segment Percentages, By Application, 2020 (%)

• Psoriasis
• Skin Infections
• Acne
• Dermatitis
• Others

Global Dermatology Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Dermatology Drug Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Dermatology Drug revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Dermatology Drug revenues share in global market, 2020 (%)

Key companies Dermatology Drug sales in global market, 2016-2021 (Estimated), (K Units)

Key companies Dermatology Drug sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• Johnson & Johnson
• Bayer
• Galderma
• Bristol-Myers Squibb
• Novartis
• Pfizer
• Merz Pharma
• Valeant
• LEO Pharma
• GlaxoSmithKline

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Dermatology Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Dermatology Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DERMATOLOGY DRUG OVERALL MARKET SIZE

2.1 Global Dermatology Drug Market Size: 2021 VS 2027
2.2 Global Dermatology Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Dermatology Drug Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Dermatology Drug Players in Global Market
3.2 Top Global Dermatology Drug Companies Ranked by Revenue
3.3 Global Dermatology Drug Revenue by Companies
3.4 Global Dermatology Drug Sales by Companies
3.5 Global Dermatology Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Dermatology Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Dermatology Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dermatology Drug Players in Global Market
  3.8.1 List of Global Tier 1 Dermatology Drug Companies
  3.8.2 List of Global Tier 2 and Tier 3 Dermatology Drug Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Dermatology Drug Market Size Markets, 2021 & 2027
  4.1.2 External Use
  4.1.3 Oral
  4.1.4 Injection
4.2 By Type - Global Dermatology Drug Revenue & Forecasts
  4.2.1 By Type - Global Dermatology Drug Revenue, 2016-2021
  4.2.2 By Type - Global Dermatology Drug Revenue, 2022-2027
  4.2.3 By Type - Global Dermatology Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Dermatology Drug Sales & Forecasts
  4.3.1 By Type - Global Dermatology Drug Sales, 2016-2021
  4.3.2 By Type - Global Dermatology Drug Sales, 2022-2027
  4.3.3 By Type - Global Dermatology Drug Sales Market Share, 2016-2027
4.4 By Type - Global Dermatology Drug Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Dermatology Drug Market Size, 2021 & 2027
  5.1.2 Psoriasis
  5.1.3 Skin Infections
  5.1.4 Acne
  5.1.5 Dermatitis
  5.1.6 Others
5.2 By Application - Global Dermatology Drug Revenue & Forecasts
  5.2.1 By Application - Global Dermatology Drug Revenue, 2016-2021
  5.2.2 By Application - Global Dermatology Drug Revenue, 2022-2027
  5.2.3 By Application - Global Dermatology Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Dermatology Drug Sales & Forecasts
  5.3.1 By Application - Global Dermatology Drug Sales, 2016-2021
  5.3.2 By Application - Global Dermatology Drug Sales, 2022-2027
  5.3.3 By Application - Global Dermatology Drug Sales Market Share, 2016-2027
5.4 By Application - Global Dermatology Drug Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Dermatology Drug Market Size, 2021 & 2027
6.2 By Region - Global Dermatology Drug Revenue & Forecasts
  6.2.1 By Region - Global Dermatology Drug Revenue, 2016-2021
  6.2.2 By Region - Global Dermatology Drug Revenue, 2022-2027
  6.2.3 By Region - Global Dermatology Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Dermatology Drug Sales & Forecasts
  6.3.1 By Region - Global Dermatology Drug Sales, 2016-2021
  6.3.2 By Region - Global Dermatology Drug Sales, 2022-2027
  6.3.3 By Region - Global Dermatology Drug Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Dermatology Drug Revenue, 2016-2027
  6.4.2 By Country - North America Dermatology Drug Sales, 2016-2027
  6.4.3 US Dermatology Drug Market Size, 2016-2027
  6.4.4 Canada Dermatology Drug Market Size, 2016-2027
  6.4.5 Mexico Dermatology Drug Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Dermatology Drug Revenue, 2016-2027
  6.5.2 By Country - Europe Dermatology Drug Sales, 2016-2027
  6.5.3 Germany Dermatology Drug Market Size, 2016-2027
  6.5.4 France Dermatology Drug Market Size, 2016-2027
  6.5.5 U.K. Dermatology Drug Market Size, 2016-2027
  6.5.6 Italy Dermatology Drug Market Size, 2016-2027
  6.5.7 Russia Dermatology Drug Market Size, 2016-2027
  6.5.8 Nordic Countries Dermatology Drug Market Size, 2016-2027
  6.5.9 Benelux Dermatology Drug Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Dermatology Drug Revenue, 2016-2027
  6.6.2 By Region - Asia Dermatology Drug Sales, 2016-2027
  6.6.3 China Dermatology Drug Market Size, 2016-2027
  6.6.4 Japan Dermatology Drug Market Size, 2016-2027
  6.6.5 South Korea Dermatology Drug Market Size, 2016-2027
  6.6.6 Southeast Asia Dermatology Drug Market Size, 2016-2027
  6.6.7 India Dermatology Drug Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Dermatology Drug Revenue, 2016-2027
  6.7.2 By Country - South America Dermatology Drug Sales, 2016-2027
  6.7.3 Brazil Dermatology Drug Market Size, 2016-2027
  6.7.4 Argentina Dermatology Drug Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Dermatology Drug Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Dermatology Drug Sales, 2016-2027
  6.8.3 Turkey Dermatology Drug Market Size, 2016-2027
  6.8.4 Israel Dermatology Drug Market Size, 2016-2027
  6.8.5 Saudi Arabia Dermatology Drug Market Size, 2016-2027
  6.8.6 UAE Dermatology Drug Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 AbbVie
  7.1.1 AbbVie Corporate Summary
  7.1.2 AbbVie Business Overview
  7.1.3 AbbVie Dermatology Drug Major Product Offerings
  7.1.4 AbbVie Dermatology Drug Sales and Revenue in Global (2016-2021)
  7.1.5 AbbVie Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson Dermatology Drug Major Product Offerings
  7.2.4 Johnson & Johnson Dermatology Drug Sales and Revenue in Global (2016-2021)
  7.2.5 Johnson & Johnson Key News
7.3 Bayer
  7.3.1 Bayer Corporate Summary
  7.3.2 Bayer Business Overview
  7.3.3 Bayer Dermatology Drug Major Product Offerings
  7.3.4 Bayer Dermatology Drug Sales and Revenue in Global (2016-2021)
  7.3.5 Bayer Key News
7.4 Galderma
  7.4.1 Galderma Corporate Summary
  7.4.2 Galderma Business Overview
  7.4.3 Galderma Dermatology Drug Major Product Offerings
  7.4.4 Galderma Dermatology Drug Sales and Revenue in Global (2016-2021)
  7.4.5 Galderma Key News
7.5 Bristol-Myers Squibb
  7.5.1 Bristol-Myers Squibb Corporate Summary
  7.5.2 Bristol-Myers Squibb Business Overview
  7.5.3 Bristol-Myers Squibb Dermatology Drug Major Product Offerings
  7.5.4 Bristol-Myers Squibb Dermatology Drug Sales and Revenue in Global (2016-2021)
  7.5.5 Bristol-Myers Squibb Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Dermatology Drug Major Product Offerings
  7.6.4 Novartis Dermatology Drug Sales and Revenue in Global (2016-2021)
  7.6.5 Novartis Key News
7.7 Pfizer
  7.7.1 Pfizer Corporate Summary
  7.7.2 Pfizer Business Overview
  7.7.3 Pfizer Dermatology Drug Major Product Offerings
  7.4.4 Pfizer Dermatology Drug Sales and Revenue in Global (2016-2021)
  7.7.5 Pfizer Key News
7.8 Merz Pharma
  7.8.1 Merz Pharma Corporate Summary
  7.8.2 Merz Pharma Business Overview
  7.8.3 Merz Pharma Dermatology Drug Major Product Offerings
  7.8.4 Merz Pharma Dermatology Drug Sales and Revenue in Global (2016-2021)
  7.8.5 Merz Pharma Key News
7.9 Valeant
  7.9.1 Valeant Corporate Summary
  7.9.2 Valeant Business Overview
  7.9.3 Valeant Dermatology Drug Major Product Offerings
  7.9.4 Valeant Dermatology Drug Sales and Revenue in Global (2016-2021)
  7.9.5 Valeant Key News
7.10 LEO Pharma
  7.10.1 LEO Pharma Corporate Summary
  7.10.2 LEO Pharma Business Overview
  7.10.3 LEO Pharma Dermatology Drug Major Product Offerings
  7.10.4 LEO Pharma Dermatology Drug Sales and Revenue in Global (2016-2021)
  7.10.5 LEO Pharma Key News
7.11 GlaxoSmithKline
  7.11.1 GlaxoSmithKline Corporate Summary
  7.11.2 GlaxoSmithKline Dermatology Drug Business Overview
  7.11.3 GlaxoSmithKline Dermatology Drug Major Product Offerings
  7.11.4 GlaxoSmithKline Dermatology Drug Sales and Revenue in Global (2016-2021)
  7.11.5 GlaxoSmithKline Key News

8 GLOBAL DERMATOLOGY DRUG PRODUCTION CAPACITY, ANALYSIS

8.1 Global Dermatology Drug Production Capacity, 2016-2027
8.2 Dermatology Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Dermatology Drug Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 DERMATOLOGY DRUG SUPPLY CHAIN ANALYSIS

10.1 Dermatology Drug Industry Value Chain
10.2 Dermatology Drug Upstream Market
10.3 Dermatology Drug Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Dermatology Drug Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Dermatology Drug in Global Market
Table 2. Top Dermatology Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Dermatology Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Dermatology Drug Revenue Share by Companies, 2016-2021
Table 5. Global Dermatology Drug Sales by Companies, (K Units), 2016-2021
Table 6. Global Dermatology Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Dermatology Drug Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Dermatology Drug Product Type
Table 9. List of Global Tier 1 Dermatology Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dermatology Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Dermatology Drug Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Dermatology Drug Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Dermatology Drug Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Dermatology Drug Sales (K Units), 2016-2021
Table 15. By Type - Global Dermatology Drug Sales (K Units), 2022-2027
Table 16. By Application – Global Dermatology Drug Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Dermatology Drug Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Dermatology Drug Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Dermatology Drug Sales (K Units), 2016-2021
Table 20. By Application - Global Dermatology Drug Sales (K Units), 2022-2027
Table 21. By Region – Global Dermatology Drug Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Dermatology Drug Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Dermatology Drug Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Dermatology Drug Sales (K Units), 2016-2021
Table 25. By Region - Global Dermatology Drug Sales (K Units), 2022-2027
Table 26. By Country - North America Dermatology Drug Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Dermatology Drug Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Dermatology Drug Sales, (K Units), 2016-2021
Table 29. By Country - North America Dermatology Drug Sales, (K Units), 2022-2027
Table 30. By Country - Europe Dermatology Drug Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Dermatology Drug Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Dermatology Drug Sales, (K Units), 2016-2021
Table 33. By Country - Europe Dermatology Drug Sales, (K Units), 2022-2027
Table 34. By Region - Asia Dermatology Drug Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Dermatology Drug Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Dermatology Drug Sales, (K Units), 2016-2021
Table 37. By Region - Asia Dermatology Drug Sales, (K Units), 2022-2027
Table 38. By Country - South America Dermatology Drug Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Dermatology Drug Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Dermatology Drug Sales, (K Units), 2016-2021
Table 41. By Country - South America Dermatology Drug Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Dermatology Drug Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Dermatology Drug Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Dermatology Drug Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Dermatology Drug Sales, (K Units), 2022-2027
Table 46. AbbVie Corporate Summary
Table 47. AbbVie Dermatology Drug Product Offerings
Table 48. AbbVie Dermatology Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Johnson & Johnson Corporate Summary
Table 50. Johnson & Johnson Dermatology Drug Product Offerings
Table 51. Johnson & Johnson Dermatology Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Bayer Corporate Summary
Table 53. Bayer Dermatology Drug Product Offerings
Table 54. Bayer Dermatology Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Galderma Corporate Summary
Table 56. Galderma Dermatology Drug Product Offerings
Table 57. Galderma Dermatology Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Bristol-Myers Squibb Corporate Summary
Table 59. Bristol-Myers Squibb Dermatology Drug Product Offerings
Table 60. Bristol-Myers Squibb Dermatology Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Novartis Corporate Summary
Table 62. Novartis Dermatology Drug Product Offerings
Table 63. Novartis Dermatology Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Pfizer Corporate Summary
Table 65. Pfizer Dermatology Drug Product Offerings
Table 66. Pfizer Dermatology Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Merz Pharma Corporate Summary
Table 68. Merz Pharma Dermatology Drug Product Offerings
Table 69. Merz Pharma Dermatology Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 70. Valeant Corporate Summary
Table 71. Valeant Dermatology Drug Product Offerings
Table 72. Valeant Dermatology Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 73. LEO Pharma Corporate Summary
Table 74. LEO Pharma Dermatology Drug Product Offerings
Table 75. LEO Pharma Dermatology Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 76. GlaxoSmithKline Corporate Summary
Table 77. GlaxoSmithKline Dermatology Drug Product Offerings
Table 78. GlaxoSmithKline Dermatology Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 79. Dermatology Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 80. Global Dermatology Drug Capacity Market Share of Key Manufacturers, 2019-2021
Table 81. Global Dermatology Drug Production by Region, 2016-2021 (K Units)
Table 82. Global Dermatology Drug Production by Region, 2022-2027 (K Units)
Table 83. Dermatology Drug Market Opportunities & Trends in Global Market
Table 84. Dermatology Drug Market Drivers in Global Market
Table 85. Dermatology Drug Market Restraints in Global Market
Table 86. Dermatology Drug Raw Materials
Table 87. Dermatology Drug Raw Materials Suppliers in Global Market
Table 88. Typical Dermatology Drug Downstream
Table 89. Dermatology Drug Downstream Clients in Global Market
Table 90. Dermatology Drug Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Dermatology Drug Segment by Type
Figure 2. Dermatology Drug Segment by Application
Figure 3. Global Dermatology Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Dermatology Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Dermatology Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. Dermatology Drug Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Dermatology Drug Revenue in 2020
Figure 9. By Type - Global Dermatology Drug Sales Market Share, 2016-2027
Figure 10. By Type - Global Dermatology Drug Revenue Market Share, 2016-2027
Figure 11. By Type - Global Dermatology Drug Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Dermatology Drug Sales Market Share, 2016-2027
Figure 13. By Application - Global Dermatology Drug Revenue Market Share, 2016-2027
Figure 14. By Application - Global Dermatology Drug Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Dermatology Drug Sales Market Share, 2016-2027
Figure 16. By Region - Global Dermatology Drug Revenue Market Share, 2016-2027
Figure 17. By Country - North America Dermatology Drug Revenue Market Share, 2016-2027
Figure 18. By Country - North America Dermatology Drug Sales Market Share, 2016-2027
Figure 19. US Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Dermatology Drug Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Dermatology Drug Sales Market Share, 2016-2027
Figure 24. Germany Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 25. France Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Dermatology Drug Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Dermatology Drug Sales Market Share, 2016-2027
Figure 33. China Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 37. India Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Dermatology Drug Revenue Market Share, 2016-2027
Figure 39. By Country - South America Dermatology Drug Sales Market Share, 2016-2027
Figure 40. Brazil Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Dermatology Drug Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Dermatology Drug Sales Market Share, 2016-2027
Figure 44. Turkey Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Dermatology Drug Revenue, (US$, Mn), 2016-2027
Figure 48. Global Dermatology Drug Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Dermatology Drug by Region, 2020 VS 2027
Figure 50. Dermatology Drug Industry Value Chain
Figure 51. Marketing Channels